 Antiretroviral therapy and demand for HIV testing: Evidence from ZambiaEconomics & Human Biology, 2016, vol. 21, issue C, 221-240 Abstract: This paper examines the effects of antiretroviral therapy (ART) on demand for HIV testing and of ART-induced testing on demand for risky sexual behavior. I provide a model of sexual behavior decision-making under uncertainty and estimate the structural parameters of the model using nationally representative survey data from Zambia on HIV testing decisions before and after the introduction of ART. The empirical results indicate that although the introduction of ART appears to have increased HIV testing rates by upwards of 50 percent, the ART allocation process may have limited the prevention benefit of ART-induced testing. Simulation results show that eliminating this prevention inefficiency while holding the supply of ART constant would increase the prevention impact of ART-induced testing more than four-fold. More generally, the analysis indicates that existing studies which examine “universal” testing or quasi-experimental testing programs understate the efficacy of standard voluntary counseling and testing programs. Keywords: HIV/AIDS; Beliefs; Selection; Rationing; Zambia (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:eee:ehbiol:v:21:y:2016:i:c:p:221-240 DOI: 10.1016/j.ehb.2016.02.003 Access Statistics for this article Economics & Human Biology is currently edited by J. Komlos, Inas R Kelly and Joerg Baten More articles in Economics & Human Biology from Elsevier |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.